Städtisches Klinikum Karlsruhe

Hospital


Location: Karlsruhe, Germany (DE) DE

ISNI: 0000000403910800

ROR: https://ror.org/00agtat91

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Biallelic Mutations in NBAS Cause Recurrent Acute Liver Failure with Onset in Infancy (2015) Haack TB, Staufner C, Koepke MG, Straub BK, Koelker S, Thiel C, Freisinger P, et al. Journal article Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases (2015) Budach W, Matuschek C, Boelke E, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases (2015) Budach W, Matuschek C, Bölke E, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV (2015) Saussele S, Krauss MP, Hehlmann R, Lauseker M, Proetel U, Kalmanti L, Hanfstein B, et al. Journal article Spincter preservation after selective chemoradiotherapy of rectal cancer : Interim results of the OCUM study (2015) Baral J, Schon MR, Ruppert R, Ptok H, Strassburg J, Brosi P, Kreis ME, et al. Journal article Romancing the Boost - the Higher, the Better? (2015) Sedlmayer F, Sautter-Bihl ML, Sauer R Journal article Identification of novel genetic markers of breast cancer survival (2015) Guo Q, Schmidt MK, Kraft P, Canisius S, Chen C, Khan S, Tyrer J, et al. Journal article Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) Lei J, Rudolph A, Moysich KB, Rafiq S, Behrens S, Goode EL, Pharoah PP, et al. Journal article Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial (2015) Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, et al. Journal article Common germline polymorphisms associated with breast cancer-specific survival (2015) Pirie A, Guo Q, Kraft P, Canisius S, Eccles DM, Rahman N, Nevanlinna H, et al. Journal article